The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Tumor Profiling Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Cancer Tumor Profiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Tumor Profiling market size is estimated to be worth US$ 40550 million in 2021 and is forecast to a readjusted size of USD 78790 million by 2028 with a CAGR of 10.0% during review period. Personalized Medicine accounting for % of the Cancer Tumor Profiling global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-generation Sequencing (NGS) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cancer Tumor Profiling include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., and NeoGenomics Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Tumor Profiling market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Market segment by Application, can be divided into
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Market segment by players, this report covers
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Tumor Profiling product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Tumor Profiling, with revenue, gross margin and global market share of Cancer Tumor Profiling from 2019 to 2022.
Chapter 3, the Cancer Tumor Profiling competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Tumor Profiling market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Tumor Profiling research findings and conclusion, appendix and data source.
Geographical Area
Global
The Cancer Tumor Profiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Tumor Profiling market size is estimated to be worth US$ 40550 million in 2021 and is forecast to a readjusted size of USD 78790 million by 2028 with a CAGR of 10.0% during review period. Personalized Medicine accounting for % of the Cancer Tumor Profiling global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-generation Sequencing (NGS) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cancer Tumor Profiling include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., and NeoGenomics Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Tumor Profiling market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Market segment by Application, can be divided into
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Market segment by players, this report covers
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Tumor Profiling product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Tumor Profiling, with revenue, gross margin and global market share of Cancer Tumor Profiling from 2019 to 2022.
Chapter 3, the Cancer Tumor Profiling competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Tumor Profiling market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Tumor Profiling research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Cancer Tumor Profiling
1.2 Classification of Cancer Tumor Profiling by Type
1.2.1 Overview: Global Cancer Tumor Profiling Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Cancer Tumor Profiling Revenue Market Share by Type in 2021
1.2.3 Next-generation Sequencing (NGS)
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 Immunohistochemistry (IHC)
1.2.6 In Situ Hybridization (ISH)
1.2.7 Microarray
1.2.8 Others
1.3 Global Cancer Tumor Profiling Market by Application
1.3.1 Overview: Global Cancer Tumor Profiling Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Personalized Medicine
1.3.3 Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Prognostics
1.3.6 Research Applications
1.4 Global Cancer Tumor Profiling Market Size & Forecast
1.5 Global Cancer Tumor Profiling Market Size and Forecast by Region
1.5.1 Global Cancer Tumor Profiling Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Cancer Tumor Profiling Market Size by Region, (2017-2022)
1.5.3 North America Cancer Tumor Profiling Market Size and Prospect (2017-2028)
1.5.4 Europe Cancer Tumor Profiling Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Cancer Tumor Profiling Market Size and Prospect (2017-2028)
1.5.6 South America Cancer Tumor Profiling Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Cancer Tumor Profiling Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Tumor Profiling Market Drivers
1.6.2 Cancer Tumor Profiling Market Restraints
1.6.3 Cancer Tumor Profiling Trends Analysis
2 Company Profiles
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business
2.1.3 Qiagen N.V. Cancer Tumor Profiling Product and Solutions
2.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Qiagen N.V. Recent Developments and Future Plans
2.2 Roche Molecular Systems Inc.
2.2.1 Roche Molecular Systems Inc. Details
2.2.2 Roche Molecular Systems Inc. Major Business
2.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
2.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Roche Molecular Systems Inc. Recent Developments and Future Plans
2.3 Abott Molecular
2.3.1 Abott Molecular Details
2.3.2 Abott Molecular Major Business
2.3.3 Abott Molecular Cancer Tumor Profiling Product and Solutions
2.3.4 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Abott Molecular Recent Developments and Future Plans
2.4 Illumina Inc.
2.4.1 Illumina Inc. Details
2.4.2 Illumina Inc. Major Business
2.4.3 Illumina Inc. Cancer Tumor Profiling Product and Solutions
2.4.4 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Illumina Inc. Recent Developments and Future Plans
2.5 NeoGenomics Laboratories
2.5.1 NeoGenomics Laboratories Details
2.5.2 NeoGenomics Laboratories Major Business
2.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
2.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.6 HTG Molecular Diagnostic
2.6.1 HTG Molecular Diagnostic Details
2.6.2 HTG Molecular Diagnostic Major Business
2.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
2.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 HTG Molecular Diagnostic Recent Developments and Future Plans
2.7 Genomic Health Inc.
2.7.1 Genomic Health Inc. Details
2.7.2 Genomic Health Inc. Major Business
2.7.3 Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
2.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Genomic Health Inc. Recent Developments and Future Plans
2.8 Hologic Gen-Probe
2.8.1 Hologic Gen-Probe Details
2.8.2 Hologic Gen-Probe Major Business
2.8.3 Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
2.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Hologic Gen-Probe Recent Developments and Future Plans
2.9 BD Biosciences
2.9.1 BD Biosciences Details
2.9.2 BD Biosciences Major Business
2.9.3 BD Biosciences Cancer Tumor Profiling Product and Solutions
2.9.4 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BD Biosciences Recent Developments and Future Plans
2.10 Siemens Healthineers
2.10.1 Siemens Healthineers Details
2.10.2 Siemens Healthineers Major Business
2.10.3 Siemens Healthineers Cancer Tumor Profiling Product and Solutions
2.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Siemens Healthineers Recent Developments and Future Plans
2.11 Claris Life Sciences
2.11.1 Claris Life Sciences Details
2.11.2 Claris Life Sciences Major Business
2.11.3 Claris Life Sciences Cancer Tumor Profiling Product and Solutions
2.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Claris Life Sciences Recent Developments and Future Plans
2.12 Personal Genome Diagnostics, Inc.
2.12.1 Personal Genome Diagnostics, Inc. Details
2.12.2 Personal Genome Diagnostics, Inc. Major Business
2.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
2.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
2.13 Perthera, Inc.
2.13.1 Perthera, Inc. Details
2.13.2 Perthera, Inc. Major Business
2.13.3 Perthera, Inc. Cancer Tumor Profiling Product and Solutions
2.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Perthera, Inc. Recent Developments and Future Plans
2.14 Foundation Medicine, Inc
2.14.1 Foundation Medicine, Inc Details
2.14.2 Foundation Medicine, Inc Major Business
2.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
2.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Foundation Medicine, Inc Recent Developments and Future Plans
2.15 V., Strand
2.15.1 V., Strand Details
2.15.2 V., Strand Major Business
2.15.3 V., Strand Cancer Tumor Profiling Product and Solutions
2.15.4 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 V., Strand Recent Developments and Future Plans
2.16 ApoCell
2.16.1 ApoCell Details
2.16.2 ApoCell Major Business
2.16.3 ApoCell Cancer Tumor Profiling Product and Solutions
2.16.4 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 ApoCell Recent Developments and Future Plans
2.17 Contextual Genomics
2.17.1 Contextual Genomics Details
2.17.2 Contextual Genomics Major Business
2.17.3 Contextual Genomics Cancer Tumor Profiling Product and Solutions
2.17.4 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Contextual Genomics Recent Developments and Future Plans
2.18 Agendia
2.18.1 Agendia Details
2.18.2 Agendia Major Business
2.18.3 Agendia Cancer Tumor Profiling Product and Solutions
2.18.4 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Agendia Recent Developments and Future Plans
2.19 GenScript
2.19.1 GenScript Details
2.19.2 GenScript Major Business
2.19.3 GenScript Cancer Tumor Profiling Product and Solutions
2.19.4 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 GenScript Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Tumor Profiling Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Tumor Profiling Players Market Share in 2021
3.2.2 Top 10 Cancer Tumor Profiling Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Cancer Tumor Profiling Players Head Office, Products and Services Provided
3.4 Cancer Tumor Profiling Mergers & Acquisitions
3.5 Cancer Tumor Profiling New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Tumor Profiling Revenue and Market Share by Type (2017-2022)
4.2 Global Cancer Tumor Profiling Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Cancer Tumor Profiling Revenue Market Share by Application (2017-2022)
5.2 Global Cancer Tumor Profiling Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Tumor Profiling Revenue by Type (2017-2028)
6.2 North America Cancer Tumor Profiling Revenue by Application (2017-2028)
6.3 North America Cancer Tumor Profiling Market Size by Country
6.3.1 North America Cancer Tumor Profiling Revenue by Country (2017-2028)
6.3.2 United States Cancer Tumor Profiling Market Size and Forecast (2017-2028)
6.3.3 Canada Cancer Tumor Profiling Market Size and Forecast (2017-2028)
6.3.4 Mexico Cancer Tumor Profiling Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Tumor Profiling Revenue by Type (2017-2028)
7.2 Europe Cancer Tumor Profiling Revenue by Application (2017-2028)
7.3 Europe Cancer Tumor Profiling Market Size by Country
7.3.1 Europe Cancer Tumor Profiling Revenue by Country (2017-2028)
7.3.2 Germany Cancer Tumor Profiling Market Size and Forecast (2017-2028)
7.3.3 France Cancer Tumor Profiling Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cancer Tumor Profiling Market Size and Forecast (2017-2028)
7.3.5 Russia Cancer Tumor Profiling Market Size and Forecast (2017-2028)
7.3.6 Italy Cancer Tumor Profiling Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Tumor Profiling Revenue by Type (2017-2028)
8.2 Asia-Pacific Cancer Tumor Profiling Revenue by Application (2017-2028)
8.3 Asia-Pacific Cancer Tumor Profiling Market Size by Region
8.3.1 Asia-Pacific Cancer Tumor Profiling Revenue by Region (2017-2028)
8.3.2 China Cancer Tumor Profiling Market Size and Forecast (2017-2028)
8.3.3 Japan Cancer Tumor Profiling Market Size and Forecast (2017-2028)
8.3.4 South Korea Cancer Tumor Profiling Market Size and Forecast (2017-2028)
8.3.5 India Cancer Tumor Profiling Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cancer Tumor Profiling Market Size and Forecast (2017-2028)
8.3.7 Australia Cancer Tumor Profiling Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Tumor Profiling Revenue by Type (2017-2028)
9.2 South America Cancer Tumor Profiling Revenue by Application (2017-2028)
9.3 South America Cancer Tumor Profiling Market Size by Country
9.3.1 South America Cancer Tumor Profiling Revenue by Country (2017-2028)
9.3.2 Brazil Cancer Tumor Profiling Market Size and Forecast (2017-2028)
9.3.3 Argentina Cancer Tumor Profiling Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Tumor Profiling Revenue by Type (2017-2028)
10.2 Middle East & Africa Cancer Tumor Profiling Revenue by Application (2017-2028)
10.3 Middle East & Africa Cancer Tumor Profiling Market Size by Country
10.3.1 Middle East & Africa Cancer Tumor Profiling Revenue by Country (2017-2028)
10.3.2 Turkey Cancer Tumor Profiling Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cancer Tumor Profiling Market Size and Forecast (2017-2028)
10.3.4 UAE Cancer Tumor Profiling Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Cancer Tumor Profiling Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cancer Tumor Profiling Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Cancer Tumor Profiling Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Cancer Tumor Profiling Revenue (USD Million) by Region (2017-2022)
Table 5. Global Cancer Tumor Profiling Revenue Market Share by Region (2023-2028)
Table 6. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 7. Qiagen N.V. Major Business
Table 8. Qiagen N.V. Cancer Tumor Profiling Product and Solutions
Table 9. Qiagen N.V. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Roche Molecular Systems Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Roche Molecular Systems Inc. Major Business
Table 12. Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Solutions
Table 13. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Abott Molecular Corporate Information, Head Office, and Major Competitors
Table 15. Abott Molecular Major Business
Table 16. Abott Molecular Cancer Tumor Profiling Product and Solutions
Table 17. Abott Molecular Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Illumina Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Illumina Inc. Major Business
Table 20. Illumina Inc. Cancer Tumor Profiling Product and Solutions
Table 21. Illumina Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. NeoGenomics Laboratories Corporate Information, Head Office, and Major Competitors
Table 23. NeoGenomics Laboratories Major Business
Table 24. NeoGenomics Laboratories Cancer Tumor Profiling Product and Solutions
Table 25. NeoGenomics Laboratories Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. HTG Molecular Diagnostic Corporate Information, Head Office, and Major Competitors
Table 27. HTG Molecular Diagnostic Major Business
Table 28. HTG Molecular Diagnostic Cancer Tumor Profiling Product and Solutions
Table 29. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Genomic Health Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Genomic Health Inc. Major Business
Table 32. Genomic Health Inc. Cancer Tumor Profiling Product and Solutions
Table 33. Genomic Health Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Hologic Gen-Probe Corporate Information, Head Office, and Major Competitors
Table 35. Hologic Gen-Probe Major Business
Table 36. Hologic Gen-Probe Cancer Tumor Profiling Product and Solutions
Table 37. Hologic Gen-Probe Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. BD Biosciences Corporate Information, Head Office, and Major Competitors
Table 39. BD Biosciences Major Business
Table 40. BD Biosciences Cancer Tumor Profiling Product and Solutions
Table 41. BD Biosciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 43. Siemens Healthineers Major Business
Table 44. Siemens Healthineers Cancer Tumor Profiling Product and Solutions
Table 45. Siemens Healthineers Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Claris Life Sciences Corporate Information, Head Office, and Major Competitors
Table 47. Claris Life Sciences Major Business
Table 48. Claris Life Sciences Cancer Tumor Profiling Product and Solutions
Table 49. Claris Life Sciences Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Personal Genome Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Personal Genome Diagnostics, Inc. Major Business
Table 52. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Solutions
Table 53. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Perthera, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Perthera, Inc. Major Business
Table 56. Perthera, Inc. Cancer Tumor Profiling Product and Solutions
Table 57. Perthera, Inc. Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Foundation Medicine, Inc Corporate Information, Head Office, and Major Competitors
Table 59. Foundation Medicine, Inc Major Business
Table 60. Foundation Medicine, Inc Cancer Tumor Profiling Product and Solutions
Table 61. Foundation Medicine, Inc Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. V., Strand Corporate Information, Head Office, and Major Competitors
Table 63. V., Strand Major Business
Table 64. V., Strand Cancer Tumor Profiling Product and Solutions
Table 65. V., Strand Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. ApoCell Corporate Information, Head Office, and Major Competitors
Table 67. ApoCell Major Business
Table 68. ApoCell Cancer Tumor Profiling Product and Solutions
Table 69. ApoCell Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Contextual Genomics Corporate Information, Head Office, and Major Competitors
Table 71. Contextual Genomics Major Business
Table 72. Contextual Genomics Cancer Tumor Profiling Product and Solutions
Table 73. Contextual Genomics Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Agendia Corporate Information, Head Office, and Major Competitors
Table 75. Agendia Major Business
Table 76. Agendia Cancer Tumor Profiling Product and Solutions
Table 77. Agendia Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. GenScript Corporate Information, Head Office, and Major Competitors
Table 79. GenScript Major Business
Table 80. GenScript Cancer Tumor Profiling Product and Solutions
Table 81. GenScript Cancer Tumor Profiling Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Global Cancer Tumor Profiling Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 83. Global Cancer Tumor Profiling Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 84. Breakdown of Cancer Tumor Profiling by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Cancer Tumor Profiling Players Head Office, Products and Services Provided
Table 86. Cancer Tumor Profiling Mergers & Acquisitions in the Past Five Years
Table 87. Cancer Tumor Profiling New Entrants and Expansion Plans
Table 88. Global Cancer Tumor Profiling Revenue (USD Million) by Type (2017-2022)
Table 89. Global Cancer Tumor Profiling Revenue Share by Type (2017-2022)
Table 90. Global Cancer Tumor Profiling Revenue Forecast by Type (2023-2028)
Table 91. Global Cancer Tumor Profiling Revenue by Application (2017-2022)
Table 92. Global Cancer Tumor Profiling Revenue Forecast by Application (2023-2028)
Table 93. North America Cancer Tumor Profiling Revenue by Type (2017-2022) & (USD Million)
Table 94. North America Cancer Tumor Profiling Revenue by Type (2023-2028) & (USD Million)
Table 95. North America Cancer Tumor Profiling Revenue by Application (2017-2022) & (USD Million)
Table 96. North America Cancer Tumor Profiling Revenue by Application (2023-2028) & (USD Million)
Table 97. North America Cancer Tumor Profiling Revenue by Country (2017-2022) & (USD Million)
Table 98. North America Cancer Tumor Profiling Revenue by Country (2023-2028) & (USD Million)
Table 99. Europe Cancer Tumor Profiling Revenue by Type (2017-2022) & (USD Million)
Table 100. Europe Cancer Tumor Profiling Revenue by Type (2023-2028) & (USD Million)
Table 101. Europe Cancer Tumor Profiling Revenue by Application (2017-2022) & (USD Million)
Table 102. Europe Cancer Tumor Profiling Revenue by Application (2023-2028) & (USD Million)
Table 103. Europe Cancer Tumor Profiling Revenue by Country (2017-2022) & (USD Million)
Table 104. Europe Cancer Tumor Profiling Revenue by Country (2023-2028) & (USD Million)
Table 105. Asia-Pacific Cancer Tumor Profiling Revenue by Type (2017-2022) & (USD Million)
Table 106. Asia-Pacific Cancer Tumor Profiling Revenue by Type (2023-2028) & (USD Million)
Table 107. Asia-Pacific Cancer Tumor Profiling Revenue by Application (2017-2022) & (USD Million)
Table 108. Asia-Pacific Cancer Tumor Profiling Revenue by Application (2023-2028) & (USD Million)
Table 109. Asia-Pacific Cancer Tumor Profiling Revenue by Region (2017-2022) & (USD Million)
Table 110. Asia-Pacific Cancer Tumor Profiling Revenue by Region (2023-2028) & (USD Million)
Table 111. South America Cancer Tumor Profiling Revenue by Type (2017-2022) & (USD Million)
Table 112. South America Cancer Tumor Profiling Revenue by Type (2023-2028) & (USD Million)
Table 113. South America Cancer Tumor Profiling Revenue by Application (2017-2022) & (USD Million)
Table 114. South America Cancer Tumor Profiling Revenue by Application (2023-2028) & (USD Million)
Table 115. South America Cancer Tumor Profiling Revenue by Country (2017-2022) & (USD Million)
Table 116. South America Cancer Tumor Profiling Revenue by Country (2023-2028) & (USD Million)
Table 117. Middle East & Africa Cancer Tumor Profiling Revenue by Type (2017-2022) & (USD Million)
Table 118. Middle East & Africa Cancer Tumor Profiling Revenue by Type (2023-2028) & (USD Million)
Table 119. Middle East & Africa Cancer Tumor Profiling Revenue by Application (2017-2022) & (USD Million)
Table 120. Middle East & Africa Cancer Tumor Profiling Revenue by Application (2023-2028) & (USD Million)
Table 121. Middle East & Africa Cancer Tumor Profiling Revenue by Country (2017-2022) & (USD Million)
Table 122. Middle East & Africa Cancer Tumor Profiling Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Cancer Tumor Profiling Picture
Figure 2. Global Cancer Tumor Profiling Revenue Market Share by Type in 2021
Figure 3. Next-generation Sequencing (NGS)
Figure 4. Polymerase Chain Reaction (PCR)
Figure 5. Immunohistochemistry (IHC)
Figure 6. In Situ Hybridization (ISH)
Figure 7. Microarray
Figure 8. Others
Figure 9. Cancer Tumor Profiling Revenue Market Share by Application in 2021
Figure 10. Personalized Medicine Picture
Figure 11. Diagnostics Picture
Figure 12. Biomarker Discovery Picture
Figure 13. Prognostics Picture
Figure 14. Research Applications Picture
Figure 15. Global Cancer Tumor Profiling Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Cancer Tumor Profiling Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Cancer Tumor Profiling Revenue Market Share by Region (2017-2028)
Figure 18. Global Cancer Tumor Profiling Revenue Market Share by Region in 2021
Figure 19. North America Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Cancer Tumor Profiling Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Cancer Tumor Profiling Market Drivers
Figure 25. Cancer Tumor Profiling Market Restraints
Figure 26. Cancer Tumor Profiling Market Trends
Figure 27. Qiagen N.V. Recent Developments and Future Plans
Figure 28. Roche Molecular Systems Inc. Recent Developments and Future Plans
Figure 29. Abott Molecular Recent Developments and Future Plans
Figure 30. Illumina Inc. Recent Developments and Future Plans
Figure 31. NeoGenomics Laboratories Recent Developments and Future Plans
Figure 32. HTG Molecular Diagnostic Recent Developments and Future Plans
Figure 33. Genomic Health Inc. Recent Developments and Future Plans
Figure 34. Hologic Gen-Probe Recent Developments and Future Plans
Figure 35. BD Biosciences Recent Developments and Future Plans
Figure 36. Siemens Healthineers Recent Developments and Future Plans
Figure 37. Claris Life Sciences Recent Developments and Future Plans
Figure 38. Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
Figure 39. Perthera, Inc. Recent Developments and Future Plans
Figure 40. Foundation Medicine, Inc Recent Developments and Future Plans
Figure 41. V., Strand Recent Developments and Future Plans
Figure 42. ApoCell Recent Developments and Future Plans
Figure 43. Contextual Genomics Recent Developments and Future Plans
Figure 44. Agendia Recent Developments and Future Plans
Figure 45. GenScript Recent Developments and Future Plans
Figure 46. Global Cancer Tumor Profiling Revenue Share by Players in 2021
Figure 47. Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 48. Global Top 3 Players Cancer Tumor Profiling Revenue Market Share in 2021
Figure 49. Global Top 10 Players Cancer Tumor Profiling Revenue Market Share in 2021
Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 51. Global Cancer Tumor Profiling Revenue Share by Type in 2021
Figure 52. Global Cancer Tumor Profiling Market Share Forecast by Type (2023-2028)
Figure 53. Global Cancer Tumor Profiling Revenue Share by Application in 2021
Figure 54. Global Cancer Tumor Profiling Market Share Forecast by Application (2023-2028)
Figure 55. North America Cancer Tumor Profiling Sales Market Share by Type (2017-2028)
Figure 56. North America Cancer Tumor Profiling Sales Market Share by Application (2017-2028)
Figure 57. North America Cancer Tumor Profiling Revenue Market Share by Country (2017-2028)
Figure 58. United States Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Canada Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Mexico Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Europe Cancer Tumor Profiling Sales Market Share by Type (2017-2028)
Figure 62. Europe Cancer Tumor Profiling Sales Market Share by Application (2017-2028)
Figure 63. Europe Cancer Tumor Profiling Revenue Market Share by Country (2017-2028)
Figure 64. Germany Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. France Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. United Kingdom Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Russia Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Italy Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Asia-Pacific Cancer Tumor Profiling Sales Market Share by Type (2017-2028)
Figure 70. Asia-Pacific Cancer Tumor Profiling Sales Market Share by Application (2017-2028)
Figure 71. Asia-Pacific Cancer Tumor Profiling Revenue Market Share by Region (2017-2028)
Figure 72. China Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Japan Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Korea Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. India Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Southeast Asia Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Australia Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South America Cancer Tumor Profiling Sales Market Share by Type (2017-2028)
Figure 79. South America Cancer Tumor Profiling Sales Market Share by Application (2017-2028)
Figure 80. South America Cancer Tumor Profiling Revenue Market Share by Country (2017-2028)
Figure 81. Brazil Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Argentina Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Middle East and Africa Cancer Tumor Profiling Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Cancer Tumor Profiling Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Cancer Tumor Profiling Revenue Market Share by Country (2017-2028)
Figure 86. Turkey Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. Saudi Arabia Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. UAE Cancer Tumor Profiling Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Methodology
Figure 90. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
